AU2003213327A1 - Adipocyte differentiation inhibitor - Google Patents

Adipocyte differentiation inhibitor

Info

Publication number
AU2003213327A1
AU2003213327A1 AU2003213327A AU2003213327A AU2003213327A1 AU 2003213327 A1 AU2003213327 A1 AU 2003213327A1 AU 2003213327 A AU2003213327 A AU 2003213327A AU 2003213327 A AU2003213327 A AU 2003213327A AU 2003213327 A1 AU2003213327 A1 AU 2003213327A1
Authority
AU
Australia
Prior art keywords
adipocyte differentiation
differentiation inhibitor
inhibitor
adipocyte
differentiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003213327A
Inventor
Hisashi Aso
Hiroshi Nagaishi
Tsuyoshi Saito
Koji Tahara
Shoichi Takano
Tadashi Yamasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BML Inc
Original Assignee
BML Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BML Inc filed Critical BML Inc
Publication of AU2003213327A1 publication Critical patent/AU2003213327A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003213327A 2003-03-12 2003-03-12 Adipocyte differentiation inhibitor Abandoned AU2003213327A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2003/002898 WO2004080484A1 (en) 2003-03-12 2003-03-12 Adipocyte differentiation inhibitor

Publications (1)

Publication Number Publication Date
AU2003213327A1 true AU2003213327A1 (en) 2004-09-30

Family

ID=32983441

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003213327A Abandoned AU2003213327A1 (en) 2003-03-12 2003-03-12 Adipocyte differentiation inhibitor

Country Status (3)

Country Link
JP (1) JPWO2004080484A1 (en)
AU (1) AU2003213327A1 (en)
WO (1) WO2004080484A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201912490D0 (en) * 2019-08-30 2019-10-16 Univ Greenwich Treatment of obesity and related conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10279500A (en) * 1997-04-04 1998-10-20 Sumitomo Pharmaceut Co Ltd Therapeutic agent for obesity
JP2001523245A (en) * 1997-04-24 2001-11-20 メルク シヤープ エンド ドーム リミテツド Use of NK-1 receptor antagonists and SSRIs to treat obesity
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
JPWO2004080484A1 (en) 2006-06-08
WO2004080484A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
PL373146A1 (en) Pyridazinone-derivatives as pde4 inhibitors
AU2003900608A0 (en) Hdac inhibitor
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003244750A1 (en) Polymerisation inhibitor
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2002343940A1 (en) Anticorrosive
AU2003269984A1 (en) Protease inhibitors
AU2003270351A1 (en) Anesthetic-state determining
AU2003242559A1 (en) Alkylaminosiloxanes as corrosion inhibitors
AU2003263738A1 (en) Protease inhibitors
AU2003213327A1 (en) Adipocyte differentiation inhibitor
AU2003900587A0 (en) Hdac inhibitor
AU2003251587A1 (en) Multifunctional cox-2 inhibitors
AU2003248939A1 (en) Continuous steelmaking plant
AU2003304496A1 (en) Protease inhibitors
AU2003233642A1 (en) Protease inhibitors
AU2003212130A1 (en) Can
AU2003232910A1 (en) Threaded connection
AU2003221323A1 (en) Osteoclast differentiation inhibitors
AU2003265240A1 (en) Protease inhibitors
AU2003269878A1 (en) Protease inhibitors
AU2003273794A1 (en) Magnetic inhibitor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase